<< Read Full Article
<< Read Full Article
This column originally posted on RealMoney.com at 8:09 a.m. EDT. For more information about subscribing to RealMoney, please click here.
Let's open the Biotech Mailbag.
My post-mortem on the Cell Genesys (CEGE Quote) blowup prompted a lot of email, much of it complimentary, but some not so much. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,459.49 | 1,108.73 | 2,203.27 | 36.03 |
Oil *
72.23
|
|
DOWN
41.56
|
DOWN
5.38
|
DOWN
8.83
|
UP
0.57
|
10 Yr
3.60%
SPDR Gold
109.94
|
|
-0.40%
|
-0.48%
|
-0.40%
|
+1.61%
|
Data delayed 20 minutes |
Connect with TheStreet